# Heart Outcomes Prevention and Evaluation 4

Study · id `cardio:ct-nct01826019` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01826019](<https://clinicaltrials.gov/study/NCT01826019>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01826019

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1438 participants.

## Technical summary

Registry record NCT01826019. Randomized; no masking; primary purpose health services research. Start 2014-08 (actual); primary completion 2019-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose health services research
- Phase: Phase 4
- Enrolled: 1438 participants (enrolled count; ClinicalTrials.gov record NCT01826019, source copy `cardio:ctgov-nct01826019-2019-02-21`, retrieved 2026-10-26)
- Started: 2014-08 (actual) (ClinicalTrials.gov record NCT01826019, source copy `cardio:ctgov-nct01826019-2019-02-21`, retrieved 2026-10-26)
- Primary completion: 2019-02 (actual) (ClinicalTrials.gov record NCT01826019, source copy `cardio:ctgov-nct01826019-2019-02-21`, retrieved 2026-10-26)
- Completion: 2019-02 (actual) (ClinicalTrials.gov record NCT01826019, source copy `cardio:ctgov-nct01826019-2019-02-21`, retrieved 2026-10-26)
- Countries: Canada; Colombia; Malaysia (ClinicalTrials.gov record NCT01826019, source copy `cardio:ctgov-nct01826019-2019-02-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01826019-2019-02-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Heart Outcomes Prevention and Evaluation 4
- Acronym: HOPE-4
- Condition: Hypertension
- Condition: Cardiovascular Disease
- Intervention (Other): Intervention
- Intervention (Other): Usual Care
- Lead sponsor: Hamilton Health Sciences Corporation
- Lead sponsor class: OTHER
- Collaborator: Population Health Research Institute
- Collaborator class: OTHER
- Collaborator: Canadian Institutes of Health Research (CIHR)
- Collaborator class: OTHER\_GOV
- Collaborator: Grand Challenges Canada
- Collaborator class: OTHER
- Collaborator: Global Alliance for Chronic Diseases (GACD)
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Hamilton Health Sciences Corporation (`cardio:org-hamilton-health-sciences-corporation`)
- Registry lists this organization as a collaborator: Population Health Research Institute (`cardio:org-population-health-research-institute`)
- Registry lists this organization as a collaborator: Canadian Institutes of Health Research (CIHR) (`cardio:org-canadian-institutes-of-health-research-cihr`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial (`cardio:pubmed-31488369`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 9b14b0b1d343f8b21c8051b6bb7bd776345be250fc4a8906aaec39becf7ccb31
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
